<DOC>
	<DOCNO>NCT00130286</DOCNO>
	<brief_summary>The purpose study determine combination recombinant human growth hormone plus rosiglitazone ( insulin-sensitizing drug ) safe effective either drug alone ( active therapy ) treatment fat accumulation people HIV infection insulin resistance .</brief_summary>
	<brief_title>Growth Hormone and/or Rosiglitazone HIV-Associated Increased Abdominal Fat Insulin Resistance</brief_title>
	<detailed_description>A number people HIV infection gain weight abdomen ( sometimes call lipodystrophy ) also high level sugar-controlling hormone call insulin . These people need produce extra insulin help keep blood sugar normal . This call `` insulin resistance . '' Studies show growth hormone ( also call `` Serostim '' ) decrease abdominal fat , also worsen insulin resistance . Rosiglitazone ( also call `` Avandia '' ) use treat insulin resistance people diabetes , want see take growth hormone rosiglitazone together well treat fat accumulation part lipodystrophy either drug alone active therapy . The study 24 week long , divide two 12-week part . The first part study double-blind , mean neither participant study staff know drug participant . Participants assign randomly ( like flip coin ) one four group : 1 . Growth hormone ( one injection , daily ) PLUS rosiglitazone ( one tablet , twice daily ) . 2 . Growth hormone PLUS rosiglitazone placebo ( `` sugar pill '' ) . 3 . Growth hormone placebo ( plain water injection ) PLUS rosiglitazone . 4 . Growth hormone placebo PLUS rosiglitazone placebo . Everyone study need hospitalize overnight special test begin study week 12 . The second part study open-label , mean participant study staff know drug participant receive . All volunteer receive active drug : - Growth hormone ( one 2 mg injection , every day ) PLUS rosiglitazone ( one 4 mg tablet , twice daily ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Body Weight</mesh_term>
	<mesh_term>Lipodystrophy</mesh_term>
	<mesh_term>Body Weight Changes</mesh_term>
	<mesh_term>HIV-Associated Lipodystrophy Syndrome</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<criteria>HIVinfected On stable Food Drug Administration ( FDA ) approve antiretrovirals least 8 week Excess abdominal fat base waist hip measurement do screen visit . [ waist great 34.7 inch ( men ) 29.6 inch ( woman ) waist hip ratio great 0.95 ( men ) 0.9 ( woman ) ] Evidence insulin resistance ( base fast glucose insulin level do screen ) Triglycerides le 750 mg/dL Pregnancy Active AIDSdefining infection acute illness , within 30 day entry . Active cancer ( except localize Kaposi 's sarcoma ) active brain tumor Any diagnosis pancreatitis , carpal tunnel syndrome , diabetes , angina , coronary artery disease , disorder associate fluid retention ( example : cirrhosis , congestive heart failure ) Untreated uncontrolled high blood pressure , within 30 day entry . Within 12 week study entry , use following : Obesity ( fatreducing ) drug . Antidiabetic insulinsensitizing drug ( example : rosiglitazone , pioglitazone , metformin ) . Systemic glucocorticoid ( example : prednisone ) . Growth hormone medication AIDSassociated wasting . Systemic chemotherapy , interferon , radiation therapy . Androgenic agent [ example : nandrolone , oxandrolone ( Oxandrin ) ( testosterone replacement therapy permit start 30 day entry ) ] Appetite stimulant ( Marinol , Megace , Periactin ) . Use cholesterol lower drug , unless start 12 week entry Inability magnetic resonance imaging ( MRI ) scan perform ( example : cardiac pacemaker , intracranial aneurysm clip )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Lipodystrophy</keyword>
	<keyword>HIV</keyword>
	<keyword>Growth hormone</keyword>
	<keyword>Rosiglitazone</keyword>
	<keyword>Visceral fat</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>Treatment Experienced</keyword>
	<keyword>Visceral fat accumulation</keyword>
	<keyword>fat accumulation</keyword>
	<keyword>HIV-Associated Metabolic Syndrome</keyword>
</DOC>